RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more
RPG Life Sciences Limited (RPGLIFE) - Total Assets
Latest total assets as of September 2025: ₹7.06 Billion INR
Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) holds total assets worth ₹7.06 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
RPG Life Sciences Limited - Total Assets Trend (2005–2025)
This chart illustrates how RPG Life Sciences Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
RPG Life Sciences Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
RPG Life Sciences Limited's total assets of ₹7.06 Billion consist of 70.7% current assets and 29.3% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹260.00 Million | 4.4% |
| Accounts Receivable | ₹867.60 Million | 13.2% |
| Inventory | ₹929.80 Million | 14.1% |
| Property, Plant & Equipment | ₹1.65 Billion | 25.1% |
| Intangible Assets | ₹227.60 Million | 3.5% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how RPG Life Sciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RPG Life Sciences Limited's current assets represent 70.7% of total assets in 2025, an increase from 29.2% in 2005.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2025, up from 0.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is property, plant & equipment at 25.1% of total assets.
RPG Life Sciences Limited Competitors by Total Assets
Key competitors of RPG Life Sciences Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
RPG Life Sciences Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - RPG Life Sciences Limited generates 0.99x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, RPG Life Sciences Limited generates $ 27.86 in net profit.
RPG Life Sciences Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.40 | 1.97 | 1.92 |
| Quick Ratio | 2.65 | 1.38 | 1.14 |
| Cash Ratio | 0.92 | 0.20 | 0.00 |
| Working Capital | ₹3.44 Billion | ₹ 1.62 Billion | ₹ 711.80 Million |
RPG Life Sciences Limited - Advanced Valuation Insights
This section examines the relationship between RPG Life Sciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.08 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 28.3% |
| Total Assets | ₹6.58 Billion |
| Market Capitalization | $94.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values RPG Life Sciences Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: RPG Life Sciences Limited's assets grew by 28.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for RPG Life Sciences Limited (2005–2025)
The table below shows the annual total assets of RPG Life Sciences Limited from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹6.58 Billion | +28.26% |
| 2024-03-31 | ₹5.13 Billion | +22.30% |
| 2023-03-31 | ₹4.19 Billion | +21.69% |
| 2022-03-31 | ₹3.45 Billion | +13.59% |
| 2021-03-31 | ₹3.03 Billion | +13.74% |
| 2020-03-31 | ₹2.67 Billion | +6.17% |
| 2019-03-31 | ₹2.51 Billion | -13.74% |
| 2018-03-31 | ₹2.91 Billion | +18.27% |
| 2017-03-31 | ₹2.46 Billion | +20.00% |
| 2016-03-31 | ₹2.05 Billion | +4.23% |
| 2015-03-31 | ₹1.97 Billion | +0.43% |
| 2014-03-31 | ₹1.96 Billion | -4.71% |
| 2013-03-31 | ₹2.06 Billion | +12.50% |
| 2012-03-31 | ₹1.83 Billion | -4.19% |
| 2011-03-31 | ₹1.91 Billion | +14.06% |
| 2010-03-31 | ₹1.67 Billion | -0.33% |
| 2009-03-31 | ₹1.68 Billion | -4.27% |
| 2008-03-31 | ₹1.75 Billion | -14.63% |
| 2007-03-31 | ₹2.05 Billion | -6.36% |
| 2006-03-31 | ₹2.19 Billion | -6.71% |
| 2005-03-31 | ₹2.35 Billion | -- |